Trials / Conditions / Renal Disease, End Stage

Renal Disease, End Stage

12 registered clinical trials studyying Renal Disease, End Stage.

Status	Trial	Sponsor	Phase
Withdrawn	Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease NCT03063190	University of Sao Paulo General Hospital	Phase 4
Active Not Recruiting	Improving Medical Decision Making for Older Patients With End Stage Renal Disease NCT04347629	Tufts Medical Center	N/A
Completed	PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment NCT04849650	Acacia Pharma Ltd	Phase 1
Completed	Ellipsys Vascular Access System Post Market Surveillance (PS) Study NCT04484220	Medtronic Endovascular	N/A
Active Not Recruiting	Incremental Haemodialysis in Incident Patients NCT03239808	Fundación para la Formación e Investigación de los Profesionales de la Salud de Extremadura	N/A
Withdrawn	Safety and Efficacy of Apixaban in Severe Renal Impairment NCT03399305	Albert Einstein College of Medicine	—
Withdrawn	Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease NCT03062176	Virginia Commonwealth University	Phase 2
Withdrawn	Inflammation in Peritoneal Dialysis Patients: Effect of Obesity NCT01691196	University of Illinois at Chicago	—
Completed	Bosutinib In Subjects With Renal Impairment NCT01233882	Pfizer	Phase 1
Completed	Oral Paricalcitol in Kidney Transplant Recipients NCT00587158	Mayo Clinic	N/A
Completed	Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patie NCT00125775	Chinese University of Hong Kong	Phase 4
Completed	Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemod NCT00035178	Texas Biotechnology Corporation	Phase 4